FEops strengthens its position as the cloud-based digital health player in the structural heart space by introducing Artificial Intelligence into its CE marked FEops HEARTguide platform.
FEops HEARTguide is a one-in-its-kind procedure planning platform for structural heart interventions that provides physicians with unique insights to evaluate device sizing and positioning pre-operatively. The platform uses digital twin technology based on patient-specific virtual replicas of the heart, and is now being extended with AI-enabled anatomical analyses.
“Adding AI enhances the scalability of FEops HEARTguide significantly. This will help the processing of medical images providing a full anatomical analysis on top of FEops’ unique digital twin technology, ” said Peter Mortier PhD, co-founder and CTO.
FEops HEARTguide is currently commercially available in the European Union, UK, Canada and Australia for its TAVI and LAAo workflows and is expected to be regulatory cleared to enter the US market later this year for its LAAo workflow.
“With FEops HEARTguide, we aim to improve and expand personalized treatment for patients with structural heart diseases. It is our vision that combining digital twins with validated and AI-enabled anatomical analyses generates consistent and accurate data-driven insights that enhance procedure planning and periprocedural guidance in an unprecedented way,” said Matthieu De Beule PhD, co-founder and CEO.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.